Marimed Stock Investor Sentiment

MRMD Stock  USD 0.11  0.01  8.33%   
About 61% of Marimed's investor base is looking to short. The analysis of current outlook of investing in Marimed suggests that many traders are alarmed regarding Marimed's prospects. The current market sentiment, together with Marimed's historical and current headlines, can help investors time the market. In addition, many technical investors use Marimed stock news signals to limit their universe of possible portfolio assets.
Marimed otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Marimed daily returns and investor perception about the current price of Marimed as well as its diversification or hedging effects on your existing portfolios.
  
over six months ago at news.google.com         
Analysts May Need To Revise Cannabis Stock Projections For Companies Surpass EBITDA Estimates By 37M...
Google News at Macroaxis
over six months ago at news.google.com         
MariMed Inc. Q1 2024 Earnings Call Transcript - Yahoo Finance UK
Google News at Macroaxis
over six months ago at news.google.com         
Earnings call MariMed sees growth and anticipates DEA reclassification benefits - Investing.com
Google News at Macroaxis
over six months ago at news.google.com         
MariMed Reports First Quarter 2024 Earnings - Marketscreener.com
Google News at Macroaxis
over six months ago at news.google.com         
Statement From MariMed CEO And President Jon Levine Regarding The Drug Enforcement Administrations D...
Google News at Macroaxis
over six months ago at news.google.com         
Marimed CEO Jon R. Levine sells shares worth over 12000 - Investing.com
Google News at Macroaxis
over six months ago at news.google.com         
MRMD Book Value per Share - GuruFocus.com
Google News at Macroaxis
over six months ago at news.google.com         
MariMed closes acquisition of a dispensary in Illinois marking the companys 5th in that state - Yaho...
Google News at Macroaxis
over six months ago at news.google.com         
Cronos Group vs. MariMed Head-To-Head Survey - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
MariMed Closes Acquisition of Thrive Dispensary in Casey, Ill. - Cannabis Business Times
Google News at Macroaxis
over six months ago at news.google.com         
MariMed Partners with Iconic Boston Music Venues -April 10, 2024 at 0730 am EDT - Marketscreener.com
Google News at Macroaxis
over six months ago at news.google.com         
MariMed Closes Acquisition of Second Maryland Dispensary By Investing.com - Investing.com Nigeria
Google News at Macroaxis
over six months ago at news.google.com         
MariMed Announces First Quarter 2024 Earnings Date - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Cannabis Stock Falling With Bullish Sentiment Thursday Should You Add Marimed Inc To Your Portfolio ...
Google News at Macroaxis
over six months ago at news.google.com         
MariMed GLG Life Tech Head to Head Comparison - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Marimed that are available to investors today. That information is available publicly through Marimed media outlets and privately through word of mouth or via Marimed internal channels. However, regardless of the origin, that massive amount of Marimed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Marimed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Marimed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Marimed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Marimed alpha.

Marimed Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.15Dec2025Feb -25-20-15-10-50
JavaScript chart by amCharts 3.21.15Marimed Marimed Dividend Benchmark Dow Jones Industrial
       Timeline  

Complementary Tools for Marimed OTC Stock analysis

When running Marimed's price analysis, check to measure Marimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marimed is operating at the current time. Most of Marimed's value examination focuses on studying past and present price action to predict the probability of Marimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marimed's price. Additionally, you may evaluate how the addition of Marimed to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
News Freq…Investor S…